Barren pipelines abound – the drug drought of pharma.
Schering‘s promising clot drug continues to do well in trials.
Amgen and Roche go another round in court over anemia drugs – this round to Amgen.
The 2007 drug company layoff tally – sobering.
Takeda‘s experimental cholesterol drug (lapaquistat) takes a hit.
Gila monster saliva diabetes drug looking good in longer-lasting version (Amylin‘s Byetta)
OK, it’s not pharma, but it’s a very cool idea for treating skin cancer – portable, inexpensive light therapy. Fascinating.